As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.
23 Analysts have issued a Zealand Pharma forecast:
23 Analysts have issued a Zealand Pharma forecast:
Jun '25 |
+/-
%
|
||
Revenue | 9,110 9,110 |
2,376%
2,376%
|
|
Gross Profit | 9,115 9,115 |
2,623%
2,623%
|
|
EBITDA | 7,404 7,404 |
1,168%
1,168%
|
EBIT (Operating Income) EBIT | 7,379 7,379 |
1,108%
1,108%
|
Net Profit | 6,681 6,681 |
1,038%
1,038%
|
In millions DKK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.
Head office | Denmark |
CEO | Adam Steensberg |
Employees | 335 |
Founded | 1997 |
Website | www.zealandpharma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.